General Information of Drug (ID: DMP3EXG)

Drug Name
SDZ-205-557 Drug Info
Synonyms 137196-67-9
Cross-matching ID
PubChem CID
5191
ChEBI ID
CHEMBL287045
CAS Number
CAS 137196-67-9
TTD Drug ID
D0W8EP

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Spliceosome 2.03 0.00e+0 101/150 (67.33%) PUF60;LSM5;HNRNPA3;...
Metabolism of xenobiotics by cytochrome P450 -1.66 4.92e-2 49/77 (63.64%) GSTA1;UGT2B28;UGT2B4;...
Non-alcoholic fatty liver disease -1.66 4.86e-2 126/155 (81.29%) NDUFA3;RXRA;NDUFS8;...
Epithelial cell signaling in Helicobacter pylori infect... -1.68 4.40e-2 62/70 (88.57%) PLCG2;CASP3;ATP6V1C1;...
Osteoclast differentiation -1.68 4.21e-2 117/127 (92.13%) PLCG2;TYK2;SQSTM1;...
Complement and coagulation cascades -1.69 4.44e-2 76/85 (89.41%) C1S;C5AR1;PLAT;...
Collecting duct acid secretion -1.69 4.62e-2 22/27 (81.48%) ATP6V0A1;ATP6V1B2;ATP4B;...
TNF signaling pathway -1.69 4.93e-2 103/112 (91.96%) TNFRSF1B;PIK3R3;MAP2K6;...
NF-kappa B signaling pathway -1.72 4.45e-2 90/104 (86.54%) CXCL3;BIRC3;CCL4;...
Natural killer cell mediated cytotoxicity -1.79 1.92e-2 99/131 (75.57%) SH3BP2;SOS2;HLA-E;...
Legionellosis -1.95 0.00e+0 51/57 (89.47%) IL18;CASP3;CLK4;...
Pertussis -2.01 0.00e+0 64/76 (84.21%) C1S;CASP3;CALML5;...
Tuberculosis -2.05 0.00e+0 159/180 (88.33%) JAK1;HLA-DQB1;CR1;...
Leishmaniasis -2.08 0.00e+0 67/77 (87.01%) IL12A;HLA-DOB;FOS;...
Malaria -2.10 0.00e+0 44/50 (88%) IL18;ICAM1;THBS3;...
Rheumatoid arthritis -2.22 0.00e+0 78/93 (83.87%) HLA-DRA;CXCL12;HLA-DMB;...
IL-17 signaling pathway -2.23 0.00e+0 84/94 (89.36%) PTGS2;IL17RA;FADD;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H